Osteoporosis International

, Volume 25, Issue 1, pp 71–76 | Cite as

The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease

  • S. A. JamalEmail author
  • S. L. West
  • T. L. Nickolas
Original Article



We assessed the ability of the World Health Organization’s fracture risk assessment tool (FRAX), bone mineral density (BMD), and age to discriminate fracture status in adults with pre-dialysis chronic kidney disease (CKD). In adults with CKD, FRAX was able to discriminate fracture status but performed no better than BMD alone.


Patients with CKD are at increased risk for fracture but the best method to assess fracture risk is not known.


We assessed the ability of the World Health Organization’s FRAX, compared with BMD at the femoral neck (FN), and age to discriminate fracture status (prevalent clinical nonspine and/or morphometric vertebral) in men and women, 18 years and older with pre-dialysis CKD. Results are presented as area under receiver operator characteristic curves (AUC) with 95 % confidence intervals (CI).


We enrolled 353 subjects; mean age was 65 ± 14 years; weight was 79 ± 18 kg, and estimated glomerular filtration rate was 28 ml/min/1.73 m2. About one third of the subjects had a prevalent clinical nonspine and/or morphometric vertebral fracture. FRAX was able to discriminate among those with prevalent clinical nonspine fractures (AUC, 0.72; 95 % CI, 0.65–0.78), morphometric vertebral fractures (AUC, 0.66; 95 % CI, 0.59–0.73), and any fracture (AUC, 0.71; 95 % CI, 0.65–0.77). The discriminative ability of BMD at the FN alone was similar to FRAX for morphometric vertebral and any fractures; FRAX performed better than BMD for prevalent clinical nonspine fractures (AUC for BMD alone, 0.66; 95 % CI, 0.60–0.73). Compared to FRAX, the AUC for age alone was lower for all fracture types.


Among men and women with CKD, FRAX is able to discriminate fracture status but performs no better than BMD alone.


Bone mineral density Chronic kidney disease Fracture Fracture discrimination FRAX 



The Toronto site was supported by grants from The Kidney Foundation of Canada, The Physicians’ Services Incorporated Foundation, and the Canadian Institutes of Health Research (FRN: 93785). The New York site was supported by grants from the National Institutes of Health (K23 DK080139); Amgen, Young Investigator Award; and the International Society for Clinical Densitometry, Special Projects Award and a Columbia University Herbert Irving Scholar Award.

Conflicts of interest



  1. 1.
    Nickolas TL, McMahon DJ, Shane E (2006) Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17:3223–3232PubMedCrossRefGoogle Scholar
  2. 2.
    Fried LF, Biggs ML, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, Sarnak M, Siscovick D, Harris T, Cauley J, Newman AB, Robbins J (2007) Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol 18:282–286PubMedCrossRefGoogle Scholar
  3. 3.
    Dooley AC, Weiss NS, Kestenbaum B (2008) Increased risk of hip fracture among men with CKD. Am J Kidney Dis 51:38–44PubMedCrossRefGoogle Scholar
  4. 4.
    Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396–399PubMedCrossRefGoogle Scholar
  5. 5.
    Nitsch D, Mylne A, Roderick PJ, Smeeth L, Hubbard R, Fletcher A (2009) Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant 24:1539–1544PubMedCrossRefGoogle Scholar
  6. 6.
    Jamal S, Chase C, Goh Y, Richardson R, Hawker G (2002) Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. AJKD 39:843–849PubMedCrossRefGoogle Scholar
  7. 7.
    Yamaguchi T, Kanno E, Tsubota J, Shiomi T, Nakai M, Hattori S (1996) Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 19:549–555PubMedCrossRefGoogle Scholar
  8. 8.
    Nickolas TL, Stein E, Cohen A, Thomas V, Staron RB, McMahon DJ, Leonard MB, Shane E (2010) Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol 21:1371–1380PubMedCrossRefGoogle Scholar
  9. 9.
    Yenchek RH, Ix JH, Shlipak MG, Bauer DC, Rianon NJ, Kritchevsky SB, Harris TB, Newman AB, Cauley JA, Fried LF (2012) Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 7:1130–1136PubMedCrossRefGoogle Scholar
  10. 10.
    Nickolas TL (2012) BMD and fracture risk in CKD: where should we go from here? Clin J Am Soc Nephrol 7:1058–1060PubMedCrossRefGoogle Scholar
  11. 11.
    Piraino B, Chen T, Cooperstein L, Segre G, Puschett J (1988) Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30:57–62PubMedGoogle Scholar
  12. 12.
    Jamal SA, Hayden JA, Beyene J (2007) Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 49:674–681PubMedCrossRefGoogle Scholar
  13. 13.
    Urena P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, de Vernejoul MC (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18:2325–2331PubMedCrossRefGoogle Scholar
  14. 14.
    Rix M, Andreassen H, Eskildsen P, Bente L, Olgaard K (1999) Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56:1084–1093PubMedCrossRefGoogle Scholar
  15. 15.
    Nickolas TL, Leonard MB, Shane E (2008) Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74:721–731PubMedCrossRefGoogle Scholar
  16. 16.
    (2008) FRAX WHO Fracture Risk Asssessment Tool. In. World Health Organization, Geneva, SwitzerlandGoogle Scholar
  17. 17.
    Jamal SA, Gilbert J, Gordon C, Bauer DC (2006) Cortical PQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 21:543–548PubMedCrossRefGoogle Scholar
  18. 18.
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470PubMedCrossRefGoogle Scholar
  19. 19.
    National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–266Google Scholar
  20. 20.
    (1994) Assessment of osteoporotic fracture risk and its role in screening for postmenopausal osteoporosis. WHO Technical Series GenevaGoogle Scholar
  21. 21.
    Genant HK, Jergas M (2003) Assessment of prevalent and incident vertebral fractures in osteoporosis research. Osteoporos Int 14:S43–S55PubMedCrossRefGoogle Scholar
  22. 22.
    Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244PubMedCrossRefGoogle Scholar
  23. 23.
    Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046PubMedCrossRefGoogle Scholar
  24. 24.
    Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2010) Independent clinical validation of a Canadian FRAX((R)) tool: fracture prediction and model calibration. J Bone Miner Res 25:2350–2358PubMedCrossRefGoogle Scholar
  25. 25.
    Fontaine MA, Albert A, Dubois B, Saint-Remy A, Rorive G (2000) Fracture and bone mineral density in hemodialysis patients. Clin Nephrol 54:218–226PubMedGoogle Scholar
  26. 26.
    Jamal SA, Cheung AM, West SL, Lok CE (2012) Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int 23:2805–2813PubMedCrossRefGoogle Scholar
  27. 27.
    Nickolas TL, Cremers S, Zhang A, Thomas V, Stein E, Cohen A, Chauncey R, Nikkel L, Yin MT, Liu XS, Boutroy S, Staron RB, Leonard MB, McMahon DJ, Dworakowski E, Shane E (2011) Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol 22:1560–1572PubMedCrossRefGoogle Scholar
  28. 28.
    Sakhaee K, Gonzalez GB (1999) Update on renal osteodystrophy: pathogenesis and clinical management. Am J Med Sci 317:251–260PubMedCrossRefGoogle Scholar
  29. 29.
    Jamal SA (2010) Bone mass measurements in men and women with chronic kidney disease. Curr Opin Nephrol Hypertens 19:343–348PubMedCrossRefGoogle Scholar
  30. 30.
    Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS, Ball A, Weiss NS (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200–2205PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2013

Authors and Affiliations

  1. 1.University of Toronto & Women’s College Research InstituteTorontoCanada
  2. 2.Department of Medicine, Division of NephrologyColumbia University Medical CenterNew YorkUSA

Personalised recommendations